An MPS-Based 50plex Microhaplotype Assay for Forensic DNA Analysis.
Ranran ZhangJiaming XueMengyu TanDezhi ChenYuanyuan XiaoGuihong LiuYazi ZhengQiushuo WuMiao LiaoMeili LvShengqiu QuWei Bo LiangPublished in: Genes (2023)
Microhaplotypes (MHs) are widely accepted as powerful markers in forensic studies. They have the advantage of both short tandem repeats (STRs) and single nucleotide polymorphisms (SNPs), with no stutter and amplification bias, short fragments and amplicons, low mutation and recombination rates, and high polymorphisms. In this study, we constructed a panel of 50 MHs that are distributed on 21 chromosomes and analyzed them using the Multiseq multiple polymerase chain reaction (multi-PCR) targeted capture sequencing protocol based on the massively parallel sequencing (MPS) platform. The sizes of markers and amplicons ranged between 11-81 bp and 123-198 bp, respectively. The sensitivity was 0.25 ng, and the calling results were consistent with Sanger sequencing and the Integrative Genomics Viewer (IGV). It showed measurable polymorphism among sequenced 137 Southwest Chinese Han individuals. No significant deviations in the Hardy-Weinberg equilibrium (HWE) and linkage disequilibrium (LD) were found at all MHs after Bonferroni correction. Furthermore, the specificity was 1:40 for simulated two-person mixtures, and the detection rates of highly degraded single samples and mixtures were 100% and 93-100%, respectively. Moreover, animal DNA testing was incomplete and low depth. Overall, our MPS-based 50-plex MH panel is a powerful forensic tool that provides a strong supplement and enhancement for some existing panels.
Keyphrases
- single cell
- high throughput
- circulating tumor
- nucleic acid
- ionic liquid
- cell free
- genome wide
- single molecule
- randomized controlled trial
- dna damage
- wastewater treatment
- real time pcr
- label free
- dna repair
- optical coherence tomography
- oxidative stress
- molecular dynamics
- cancer therapy
- hiv testing
- molecular dynamics simulations
- circulating tumor cells